These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12412479)

  • 41. In vitro-refolding of a single-chain Fv fragment in the presence of heteroaromatic thiols.
    Patil G; Rudolph R; Lange C
    J Biotechnol; 2008 Apr; 134(3-4):218-21. PubMed ID: 18321603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
    Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
    Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Affinity purification of tagged recombinant proteins using immobilized single chain Fv fragments.
    Kipriyanov SM; Little M
    Anal Biochem; 1997 Jan; 244(1):189-91. PubMed ID: 9025933
    [No Abstract]   [Full Text] [Related]  

  • 44. Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins.
    Deonarain MP; Epenetos AA
    Br J Cancer; 1998 Feb; 77(4):537-46. PubMed ID: 9484808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dimerisation strategies for shark IgNAR single domain antibody fragments.
    Simmons DP; Abregu FA; Krishnan UV; Proll DF; Streltsov VA; Doughty L; Hattarki MK; Nuttall SD
    J Immunol Methods; 2006 Aug; 315(1-2):171-84. PubMed ID: 16962608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analog.
    Webber KO; Reiter Y; Brinkmann U; Kreitman R; Pastan I
    Mol Immunol; 1995 Mar; 32(4):249-58. PubMed ID: 7723770
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Considerations in the design and production of small anti-receptor antibody forms: optimizing gains while reducing size.
    Peterson NC; Greene MI
    Ther Immunol; 1994 Oct; 1(5):289-95. PubMed ID: 7584503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A large semi-synthetic single-chain Fv phage display library based on chicken immunoglobulin genes.
    van Wyngaardt W; Malatji T; Mashau C; Fehrsen J; Jordaan F; Miltiadou D; du Plessis DH
    BMC Biotechnol; 2004 Apr; 4():6. PubMed ID: 15059288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical applications of immunotoxins. Introduction.
    FitzGerald D; Pastan I; Robertus J
    Curr Top Microbiol Immunol; 1998; 234():1-11. PubMed ID: 9670609
    [No Abstract]   [Full Text] [Related]  

  • 50. Antigen binding forces of individually addressed single-chain Fv antibody molecules.
    Ros R; Schwesinger F; Anselmetti D; Kubon M; Schäfer R; Plückthun A; Tiefenauer L
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7402-5. PubMed ID: 9636161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Secretion of scFv antibody fragments.
    Gram H; Schmitz R; Ridder R
    Methods Mol Biol; 1998; 103():179-92. PubMed ID: 9680640
    [No Abstract]   [Full Text] [Related]  

  • 52. Intrabody construction and expression. II. A synthetic catalytic Fv fragment.
    Ohage EC; Wirtz P; Barnikow J; Steipe B
    J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognition of E. coli tryptophan synthase by single-chain Fv fragments: comparison of PCR-cloning variants with the parental antibodies.
    Brégégère F; England P; Djavadi-Ohaniance L; Bedouelle H
    J Mol Recognit; 1997; 10(4):169-81. PubMed ID: 9476520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies specific for (6-4) DNA photoproducts: cloning, antibody modeling and construction of a single-chain Fv derivative.
    Morioka H; Miura H; Kobayashi H; Koizumi T; Fujii K; Asano K; Matsunaga T; Nikaido O; Stewart JD; Ohtsuka E
    Biochim Biophys Acta; 1998 Jun; 1385(1):17-32. PubMed ID: 9630483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics.
    Weisser NE; Hall JC
    Biotechnol Adv; 2009; 27(4):502-20. PubMed ID: 19374944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of recombinant multimeric antibody fragments for tumor diagnosis and therapy.
    Power BE; Kortt AA; Hudson PJ
    Methods Mol Biol; 2003; 207():335-50. PubMed ID: 12412484
    [No Abstract]   [Full Text] [Related]  

  • 57. Concepts of antibody-mediated cancer therapy.
    Kummer U; Staerz UD
    Cancer Invest; 1993; 11(2):174-84. PubMed ID: 8462018
    [No Abstract]   [Full Text] [Related]  

  • 58. Recent developments in immunotoxin therapy.
    Ghetie MA; Vitetta ES
    Curr Opin Immunol; 1994 Oct; 6(5):707-14. PubMed ID: 7826525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant antibodies in cancer therapy.
    Nayeem MS; Khan RH
    Curr Protein Pept Sci; 2006 Apr; 7(2):165-70. PubMed ID: 16611141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Construction and characterization of RNase-based targeted therapeutics.
    Newton DL; Futami J; Ruby D; Rybak SM
    Methods Mol Biol; 2003; 207():283-304. PubMed ID: 12412481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.